RETEPLASE
UNII DQA630RIE9

Substance Identification & Data

This profile provides standardized clinical and technical data for Reteplase, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DQA630RIE9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 133652-38-7 and the RxNorm Concept ID (RxCUI) 76895. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DQA630RIE9

CAS Registry Number

133652-38-7

RxNorm Concept ID

76895

Detailed Substance Profile

Preferred Name

RETEPLASE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C90972

National Cancer Institute reference terminology for clinical and research data.

INN ID

7102

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Reteplase. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.